Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06061094
Title Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT (GMALL-EVOLVE)
Acronym GMALL-EVOLVE
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Goethe University
Indications
Therapies
Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.